Probiotics in irritable bowel syndrome - is the quest for the right strain over? Rapid review of existing guidelines and recommendations.
- 2021
- Review
- Przeglad gastroenterologiczny 16(4)
- Wojciech Marlicz
- Karolina Skonieczna-Żydecka
- Patrycja Krynicka
- Igor Łoniewski
- Grażyna Rydzewska
- PubMed: 34976247
- DOI: 10.5114/pg.2021.111766
- Low evidence
- Clinical
Our current and updated meta-analysis is in line with several reports documenting significant effects of Lactobacillus plantarum (Lp299v) in reducing the risk of global symptoms and their persistence, which could assist clinicians in making the choice for the right probiotic strain in IBS patients.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes